Announcement on Convening the Q3 2025 Performance Briefing
Filed with SSE · · 2 pages · Chinese
Shanghai Hile Bio-technology Co Ltd on 6ix
Earlier from Shanghai Hile Bio-technology
- Announcement on Resolutions of the 1st Extraordinary General Meeting in 2025
- Announcement on Adjusting the Transaction Price for Major Asset Purchase and Signing Supplementary Agreement
- Announcement on Acceptance of the Registration Application for Class III Medical Devices by the Holding Subsidiary
- Announcement on Convening the 2025 Semi-annual Performance Briefing
- Announcement on Implementation of Dividend Distribution for 2024
Later from Shanghai Hile Bio-technology
- Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025
- Announcement on Resolutions of the 17th Meeting of the 5th Board of Directors
- Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2025
- Announcement on the Progress of Acquisition of Minority Equity in Holding Subsidiary and the Completion of Industrial and Commercial Change Registration
- Announcement on the Completion of Cancellation of Some Stock Options under the 2023 Restricted Stock and Stock Option Incentive Plan
Follow Shanghai Hile Bio-technology into a list and get an email when it puts out news.
Follow Shanghai Hile Bio-technology